Skip to main content
Clinical Trials/CTRI/2024/12/077558
CTRI/2024/12/077558
Not yet recruiting
Not Applicable

Development And Evaluation Of Non – Invasive Biofeedback Device For The Pelvic Floor Muscle Training: An Exploratory Study

Hitiksha Dedania1 site in 1 country100 target enrollmentStarted: January 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Hitiksha Dedania
Enrollment
100
Locations
1
Primary Endpoint
External observation method

Overview

Brief Summary

The pelvic floor muscles play a critical role in maintaining urinary continence, supporting pelvic viscera, and facilitating sexual function.

Dysfunction or weakness in these muscles can lead to a wide range of health issues, including urinary incontinence, pelvic organ prolapse, and sexual dysfunction. One promising approach to enhance the performance of the pelvic floor muscles is through the use of biofeedback devices. The electromyography (EMG) biofeedback device applied in clinical practice is not preferred by women with urinary incontinence because it is invasive, and involves the insertion of a probe into the vagina, causing pain. This research proposal aims at development of a non-invasive device that can provide feedback regarding the strength of pelvic floor muscles (PFM) contraction of the superficial layer of pelvic floor muscles.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
45.00 Year(s) to 55.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Stress urinary incontinence symptoms Moderate symptom distress by the urogenital distress inventory (UDI 6).
  • Mild or moderately severe urinary incontinence as indicated by the (ICIQ-UI SF).

Exclusion Criteria

  • previous therapy or surgery for urinary incontinence urge incontinence, neurogenic urinary incontinence uncontrolled diabetes neurological abnormalities urinary tract infection previous therapy or surgery for urinary incontinence urge incontinence, neurogenic urinary incontinence uncontrolled diabetes neurological abnormalities urinary tract infection.

Outcomes

Primary Outcomes

External observation method

Time Frame: 0 day 30th day and 60th day

Secondary Outcomes

  • Pelvic floor impact questionnaire (PFIQ – 7)(0 day 30th day and 60th day)

Investigators

Sponsor
Hitiksha Dedania
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Hitiksha Rasik Dedania

Parul University, (PhD - Marwadi University)

Study Sites (1)

Loading locations...

Similar Trials